Aldactone and Augmentin '125' drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aldactone (spironolactone) and Augmentin '125' (amoxicillin; clavulanate potassium). Common drug interactions include cardiac failure congestive among females and pruritus among males.

The phase IV clinical study analyzes what interactions people have when they take Aldactone and Augmentin '125'. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.

What is Aldactone?

Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 46,063 Aldactone users. Check the latest studies of Aldactone.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.



On Jul, 03, 2026

92 people who take Aldactone and Augmentin '125' together, and have interactions are studied.

Aldactone and Augmentin '125' drug interactions.

What are the common drug interactions of Aldactone and Augmentin '125', by gender? *:

female:

  1. Cardiac failure congestive
  2. Pyrexia (fever)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Urinary tract infection
  5. Aspartate aminotransferase increased
  6. Asthenia (weakness)
  7. Bacteraemia (presence of bacteria in the blood)
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Dehydration (dryness resulting from the removal of water)

male:

  1. Pruritus (severe itching of the skin)
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Cholestatic liver injury (due to injury bile cannot floe from liver)
  4. Fatigue (feeling of tiredness)
  5. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  6. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  7. Hyperbilirubinaemia (excess of bilirubin in the blood)
  8. Liver disorder (liver diseases)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Transaminases increased

What are the common drug interactions of Aldactone and Augmentin '125', by age (0-1 to 60+)? *:

0-1:

  1. Angioedema (rapid swelling of the dermis)
  2. Lip swelling
  3. Local swelling (swelling at the site of some application of substance or injury)
  4. Swelling face

2-9:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Brain injury
  4. Death
  5. Emotional distress
  6. Fear
  7. Injury
  8. Multi-organ failure (multisystem organ failure)
  9. Pain
  10. Renal failure (kidney dysfunction)

10-19:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Cardiac failure
  4. Hyperbilirubinaemia (excess of bilirubin in the blood)
  5. Lung disorder (lung disease)
  6. Respiratory tract infection
  7. Bilirubin conjugated increased
  8. Pneumonia

20-29:

  1. Cardiac disorder
  2. Migraine (headache)
  3. Type 1 diabetes mellitus
  4. Cardiac failure congestive
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Joint injury
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Viral cardiomyopathy (weakness in the muscle of the heart due to viral infection)

30-39:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Suicidal ideation
  3. Urinary tract infection
  4. Alcohol abuse
  5. Drug abuse
  6. Pruritus (severe itching of the skin)
  7. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  8. Thrombocytopenia (decrease of platelets in blood)

40-49:

  1. Hepatic failure (liver failure)

50-59:

  1. Dehydration (dryness resulting from the removal of water)
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Staphylococcal infection (an infection with staphylococcus bacteria)
  4. Abdominal rigidity
  5. Alanine aminotransferase increased
  6. Angiomyolipoma (most common benign tumour of the kidney)
  7. Anxiety
  8. Aspartate aminotransferase increased
  9. Asthenia (weakness)
  10. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)

60+:

  1. Pruritus (severe itching of the skin)
  2. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  3. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  4. Blood creatinine increased
  5. Cholangiolitis (inflammation of the bile capillaries)
  6. Fall
  7. Rash
  8. Transaminases increased
  9. Oedema peripheral (superficial swelling)
  10. Blood alkaline phosphatase increased

What are the existing conditions these people have? *

  1. High Blood Pressure: 8 people, 8.70%
  2. Oedema (fluid collection in tissue): 5 people, 5.43%
  3. Hiv Infection: 5 people, 5.43%

* Approximation only. Some reports may have incomplete information.

Do you take Aldactone and Augmentin '125'?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aldactone and Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aldactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aldactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone and amoxicillin; clavulanate potassium (the active ingredients of Aldactone and Augmentin '125', respectively), and Aldactone and Augmentin '125' (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: